Clinical Trials Directory

Trials / Conditions / Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

27 registered clinical trials studyying Advanced Gastric Carcinoma — 9 currently recruiting.

StatusTrialSponsorPhase
RecruitingTotal Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737
Ukrainian Society of Clinical OncologyPhase 2 / Phase 3
Not Yet RecruitingSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcin
NCT06666166
Yunpeng LiuPhase 2
RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957
NiKang Therapeutics, Inc.Phase 1
RecruitingMulti-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gas
NCT06642857
Xiangdong Cheng—
TerminatedA Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NCT06264921
NiKang Therapeutics, Inc.Phase 1
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
RecruitingTreatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
NCT05620732
Shenzhen University General HospitalN/A
UnknownProspective Study on Double-Stapling End-to-End Gastroduodenostomy Billroth-I Anastomosis in Laparoscopy-Assis
NCT05545293
West China Hospital—
UnknownRC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer
NCT05313906
Henan Cancer HospitalPhase 2
RecruitingEfficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
NCT05226169
Asan Medical CenterPhase 3
UnknownThe Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuv
NCT05351398
Shanghai Minimally Invasive Surgery Center—
Not Yet RecruitingStudy Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma
NCT05270824
Fujian Medical UniversityPhase 3
UnknownIMM2902 in Patients With Advanced Solid Tumors Expressing HER2
NCT05805956
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Phase 1 / Phase 2
UnknownSafety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
NCT05221775
Tianjin Medical University Cancer Institute and HospitalPhase 1
CompletediTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT04808791
AHS Cancer Control AlbertaPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or C
NCT04491942
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or
NCT04535401
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
UnknownCamrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma
NCT04948125
Henan Cancer HospitalPhase 2
TerminatedA Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma
NCT04718402
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1
UnknownPersonalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)
NCT04739202
Hospices Civils de LyonPhase 2
CompletedClinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-po
NCT05997524
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 2
CompletedProspectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Bi
NCT05334849
Lin Chen—
UnknownStudy on Neoadjuvant Chemotherapy for Advanced Gastric Cancer
NCT02163291
Peking UniversityPhase 2
UnknownPhase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxal
NCT01534546
Peking UniversityPhase 3
UnknownDose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carc
NCT00881816
Nanjing Sike Pharmaceutical Co., Ltd.Phase 1
CompletedA Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
NCT00192088
Eli Lilly and CompanyPhase 2